Bekric, D.; Ocker, M.; Mayr, C.; Stintzing, S.; Ritter, M.; Kiesslich, T.; Neureiter, D.
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers 2022, 14, 1826.
https://doi.org/10.3390/cancers14071826
AMA Style
Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, Neureiter D.
Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers. 2022; 14(7):1826.
https://doi.org/10.3390/cancers14071826
Chicago/Turabian Style
Bekric, Dino, Matthias Ocker, Christian Mayr, Sebastian Stintzing, Markus Ritter, Tobias Kiesslich, and Daniel Neureiter.
2022. "Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation" Cancers 14, no. 7: 1826.
https://doi.org/10.3390/cancers14071826
APA Style
Bekric, D., Ocker, M., Mayr, C., Stintzing, S., Ritter, M., Kiesslich, T., & Neureiter, D.
(2022). Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers, 14(7), 1826.
https://doi.org/10.3390/cancers14071826